Procurement of Dihydroartemisinin/Piperaquine 20/160mg dispersible tablet ( For 2018 EC - DT)
Ethiopia Pharmaceutical Supplies Service
Tender Information
| Title | Procurement of Dihydroartemisinin/Piperaquine 20/160mg dispersible tablet ( For 2018 EC - DT) |
| Description | Procurement of Dihydroartemisinin/Piperaquine 20/160mg dispersible tablet ( For 2018 EC - DT) |
| Procuring Entity | Ethiopia Pharmaceutical Supplies Service |
| Reference No | EPSA-ICB-G-0023-2018-BID-Direct |
| Procurement Method | Direct |
| Submission Deadline | 2025-09-02 14:00:00 |
| Invitation Date | 2025-08-28 00:00:00 |
| Procurement Type | Bidding |
| Award Type | single envelop |
Contact Information
| Physical Address: | Arbegnoch street St Paulos hospital, Room 01 Adiss Ababa, Ethiopia |
| Contact Details: | Tel: +251 118125211 Email: info@epsa.gov.et |
| Mailing Address: | P.O. Box 21904, Postal Code: - |
TechnicalQualification
- •Origin of the Goods and Related Services offered:
Bidder has to provide the Statement attesting the origin of the Pharmaceutical and Medical Equipment and Related Services offered
(Ref: ITB 36.4(a)) - •Technical qualifications, competence of the bidder:
The invited bidder (manufacturer) shall be listed in the latest updated version of Global Fund Quality Assurance Policy of Malaria Pharmaceutical Products before or upon bid opening date
(Ref: ITB clause 16) - •Shelf life:
Shelf life of the products shall be > 2 years
(Ref: ITB clause 16)
LegalQualification
- •Conflict of interest :
A Bidder shall not have a conflict of interest. All Bidders found to have a conflict of interest shall be disqualified.
(Ref: ITB 36.2 (b)) - •Nationality:
Bidder have nationality in accordance with ITB Sub-Clause 4.2;
(Ref: ITB 36.2 (a))
Bid Security
Amount: 0 ETB
Terms and Conditions
All terms and conditions stated on the bid document shall be applied
Login with Google